The storied South San Francisco biotech and Roche subsidiary unearthed a covert operation to profit from years of experience and knowhow when it accused Taiwan’s JHL Biotech of stealing information through one of its senior scientists. JHL, which had scored a pact with Sanofi to market biosimilars of Genentech’s top-selling drugs, has since settled the case and agreed to shut down any related work.